Back to mobile site

More on OLMA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-7.8% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Olema Pharmaceuticals (NQ:OLMA)
Delayed: 9.94 +0.19 (1.95%)
Prev. Close $9.75  
Open$9.77 
52 Wk High$ 
52 Wk Low$ 
Day High$9.94 
Day Low$9.68 
P/E N/A  
EPS$ 
Volume930,713 

Friends, Peers and Foes (?): PFE RHBBY (more...)

Jun 1, 2026 09:05 AM Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
May 26, 2026 07:05 AM Form 8-K Olema Pharmaceuticals, For: May 26
May 22, 2026 06:54 AM H.C. Wainwright Reiterates Buy Rating on Olema Pharmaceuticals (OLMA)
May 21, 2026 05:06 PM Form 8-K Olema Pharmaceuticals, For: May 21
May 21, 2026 05:00 PM Olema Oncology reports early phase 1 data for cancer drug OP-3136
May 21, 2026 05:00 PM Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 19, 2026 04:30 PM Olema Oncology to Participate in Upcoming Investor Conferences
May 15, 2026 04:35 PM Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
May 15, 2026 12:39 PM Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
May 13, 2026 04:09 PM Citi Adjusts Catalyst Watch Names
View All Articles

Entities mentioned with OLMA

View All Entities